Azza Baraka | Health Professions | Best Researcher Award

Abduljabbar S. Ba Mahel | Biomedical | Best Researcher Award

James Kim | Stemcells | Best Researcher Award

Dr.James Kim | Stemcells | Best Researcher Award

Bioprocess Scientist at PBS Biotech Inc, United States.

Dr. James Kim is a distinguished bioprocess scientist specializing in chemical and biomolecular engineering. Currently serving at PBS Biotech Inc., he focuses on advancing bioprocessing techniques, downstream analytics, and stem cell research. His expertise extends from his postdoctoral research at the University of Washington, where he pioneered exosome analysis for cancer diagnostics using nano-flow cytometry. During his Ph.D. at Ohio State University, he explored magnetic cell separation for clinical applications and studied hydrodynamic stress in bioreactors. Dr. Kim has collaborated with prestigious institutions, including the NIH, and has made significant contributions to regenerative medicine and biomanufacturing. His research seamlessly integrates fundamental scientific principles with industrial applications, reinforcing his reputation as a leading expert in biomedical engineering.

professional profiles📖

ORCID

Education 🎓

Dr. Kim earned his Ph.D. in Chemical and Biomolecular Engineering from Ohio State University (2015–2020) under the mentorship of Dr. Jeffrey Chalmers. His doctoral research focused on developing magnetic separation techniques for clinical applications and analyzing the impact of hydrodynamic stress on cell cultures in bioreactors. Before his doctoral studies, he completed a Bachelor of Science in Engineering (B.S.E.) in Chemical Engineering from the University of Michigan (2009–2015), graduating with cum laude honors. His undergraduate studies emphasized fluidics, flow cytometry, and bioprocess engineering, providing a solid foundation for his later research in cell separation, microfluidics, and assay development. Throughout his academic career, Dr. Kim demonstrated an interdisciplinary approach, integrating principles from engineering and biomedical sciences to drive innovation in biotechnology.

work Experience💼

With a diverse background in bioprocessing and analytical development, Dr. Kim currently works as a Bioprocess Scientist at PBS Biotech Inc., where he leads efforts in process scale-up, analytics development, and product testing for stem cell biomanufacturing. Prior to this, he conducted postdoctoral research at the University of Washington (2020–2023), where he played a pivotal role in advancing nano-flow cytometry for exosome-based cancer diagnostics while collaborating with leading industry partners like Beckman Coulter and the NIH. His Ph.D. research at Ohio State University (2015–2020) involved pioneering work in magnetic separation for anemia and cancer diagnostics, as well as characterizing hydrodynamic stress in bioreactors. His extensive experience bridges fundamental research with industrial applications, making significant contributions to the fields of regenerative medicine, precision diagnostics, and biomanufacturing.

Research Focus

Dr. Kim’s research centers on advancing bioprocessing strategies, optimizing bioreactor performance, and developing innovative cell separation techniques. His work in bioprocessing and bioreactor optimization includes modeling oxygen transfer for stem cell culture to improve scalability in regenerative medicine. He has significantly contributed to flow cytometry and exosome characterization, focusing on the standardization of single-molecule flow cytometry techniques for early-stage cancer diagnostics. Additionally, his expertise in magnetic cell separation has led to novel applications in anemia, sickle cell disease, and cancer diagnostics. His interdisciplinary research aims to bridge the gap between laboratory discoveries and scalable biomanufacturing, facilitating advancements in cell therapy, regenerative medicine, and precision diagnostics.

Awards & Honors🏆 

Dr. Kim has received numerous accolades throughout his career, including a Poster Presentation Scholarship at the prestigious ECI: Cell Culture Engineering XVIII Conference in 2023, which awarded him $2,000 for his research contributions. In 2016, he earned another Poster Presentation Scholarship ($500) at the International Advanced Course on Regenerative Medicine Manufacturing. He has actively presented his work at multiple AIChE Annual Meetings between 2017 and 2019, receiving recognition for his oral and poster presentations. His collaborative research efforts with the NIH and industry leaders in the field of exosome flow cytometry have also been acknowledged, further solidifying his standing as an expert in bioprocess engineering and regenerative medicine..

Conclusion✅

Dr. James Kim is a strong candidate for the Best Researcher Award, given his significant contributions to bioprocess engineering and biomedical diagnostics. His work bridges fundamental science and industrial applications, demonstrating innovation in process and instrumentation development. While he excels in research output and industry collaboration, additional focus on patenting, professional memberships, and increasing citation impact could further strengthen his profile. Overall, he is a well-qualified contender for this award.

Publications to Noted 📚

Measurement of Oxygen Transfer Rate and Specific Oxygen Uptake Rate of h-iPSC Aggregates in Vertical Wheel Bioreactors to Predict Maximum Cell Density Before Oxygen Limitation (2025)
Authors: James Kim, Omokhowa Agbojo, Sunghoon Jung, Matt Croughan
Citations: Not available

Comparison of EV Characterization by Commercial High‐Sensitivity Flow Cytometers and a Custom Single‐Molecule Flow Cytometer (2024)
Authors: James Kim, Shihan Xu, Seung‐Ryoung Jung, Alya Nguyen, Yuanhua Cheng, Mengxia Zhao, Bryant S. Fujimoto, Wyatt Nelson, Perry Schiro, Jeffrey L. Franklin, et al.
Citations: Not available

Intrinsically Magnetic Susceptibility in Human Blood and Its Potential Impact on Cell Separation: Non-Classical and Intermediate Monocytes Have the Strongest Magnetic Behavior in Fresh Human Blood (2021)
Authors: J. Gómez-Pastora, J. Kim, V. Multanen, M. Weigand, N.A. Walters, E. Reátegui, A.F. Palmer, M.H. Yazer, M. Zborowski, J.J. Chalmers
Citations: Not available

Magnetophoretic and Spectral Characterization of Oxyhemoglobin and Deoxyhemoglobin: Chemical Versus Enzymatic Processes (2021)
Authors: M.R.H. Weigand, J. Gómez-Pastora, J. Kim, M.T. Kurek, R.J. Hickey, D.C. Irwin, P.W. Buehler, M. Zborowski, A.F. Palmer, J.J. Chalmers
Citations: Not available

Hyperferritinemia in Critically Ill COVID-19 Patients – Is Ferritin the Product of Inflammation or a Pathogenic Mediator? (2020)
Authors: J. Gómez-Pastora, M. Weigand, J. Kim, X. Wu, J. Strayer, A.F. Palmer, M. Zborowski, M. Yazer, J.J. Chalmers
Citations: Not available

Quantification of the Mean and Distribution of Hemoglobin Content in Normal Human Blood Using Cell Tracking Velocimetry (2020)
Authors: James Kim, Jenifer Gómez-Pastora, Christopher J. Gilbert, Mitchell Weigand, Nicole A. Walters, Eduardo Reátegui, Andre F. Palmer, Mark Yazer, Maciej Zborowski, Jeffrey J. Chalmers
Citations: Not available

Single Cell Analysis of Aged RBCs: Quantitative Analysis of the Aged Cells and Byproducts (2019)
Authors: J. Kim, M. Weigand, A.F. Palmer, M. Zborowski, M.H. Yazer, J.J. Chalmers
Citations: Not available

Quantitative Characterization of the Regulation of Iron Metabolism in Glioblastoma Stem‐Like Cells Using Magnetophoresis (2019)
Authors: Kyoung‐Joo J. Park, James Kim, Thomas Testoff, Joseph Adams, Miranda Poklar, Maciej Zborowski, Monica Venere, Jeffrey J. Chalmers
Citations: Not available

A Subpopulation of Monocytes in Normal Human Blood Has Significant Magnetic Susceptibility: Quantification and Potential Implications (2019)
Authors: James Kim, Jenifer Gómez‐Pastora, Mitchell Weigand, Marnie Potgieter, Nicole A. Walters, Eduardo Reátegui, Andre F. Palmer, Mark Yazer, Maciej Zborowski, Jeffrey J. Chalmers
Citations: Not available

Correlation of Simulation/Finite Element Analysis to the Separation of Intrinsically Magnetic Spores and Red Blood Cells Using a Microfluidic Magnetic Deposition System (2018)
Authors: J. Sun, L. Moore, W. Xue, J. Kim, M. Zborowski, J.J. Chalmers
Citations: Not available

 

 

EMMANUEL SCALAIS | Medicine and Health Sciences | Outstanding Scientist Award

Dr.EMMANUELSCALAIS|MedicineandHealth Sciences| Outstanding Scientist Award

MD at NEPE, Luxembourg.

Dr. Emmanuel Scalais is the Chief Physician of the Pediatric Neurology Department at Centre Hospitalier de Luxembourg (CHL)He has authored 82 publications and has been cited 2,877 times in the field of pediatric neurology.His clinical expertise includes conditions such as homocystinuria, vitamin B12 deficiency anemia, and exocrine pancreatic insufficiency.

professional profiles📖

Education 🎓

Secondary School: Humanity Greco-Latine (June 1972), Collège du Sacré-Coeur, Charleroi, BelgiumHigh School: Université Catholique de LouvainBaccalauréat en Philosophie: Magna cum Laude (June 1975)Doctor of Medicine: Laude (June 1979)

work Experience💼

1988-2002: Pediatric Neurologist, CHC Espérance & Saint Vincent, Liège, Belgium (Full-time)Lecturer: Pediatric Neurology Course for nurses at “School of Sainte-Julienne,” LiègeLecturer: “Medical Approach of Handicap” in Orthopédagogie2003-2024: Pediatric Neurologist, Centre Hospitalier de Luxembourg, Department of Pediatrics (Full-time)Head of Pediatric Neurology Division (2014-2018, 2018-2024)Lecturer: Pediatric Neurology Course for nurses at “Lycée Technique pour Professions de Santé” (2006-2024)

Research Focus

Dr. Scalais has authored numerous peer-reviewed articles, with a focus on pediatric neurology, metabolic disorders, and neonatal brain function. Notable contributions include:Research on phenobarbital’s effects on cerebral blood flow in newbornsStudies on very long-chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant deathInvestigations into early myoclonic epilepsy linked to CoQ10 deficiencyDiagnostic and prognostic value of evoked potentials in neonatal hypoxiaCase studies on mitochondrial disorders, such as Leigh’s encephalopathy and POLG mutationsHydroxocobalamin dose intensification in early-onset cobalamin metabolism defects

Conclusion

Dr. Scalais based on his , , and . While increasing could further strengthen his profile, his current body of work already demonstrates and .is highly suitable for this awardsignificant contributions to pediatric neurology researchclinical impactinternational collaborationshigh-impact publications, principal investigator roles, and research fundingoutstanding scientific meritlong-term dedication to pediatric neurology

📚Publications to Noted

  • Scalais E, Beharry K, Papageorgiou A, Bureau M, Aranda JV (1992). Effects of phenobarbital on cerebral blood flow in the newborn piglet. Developmental Pharmacology and Therapeutics, 19(1), 10-18. [doi: 10.1159/000457457]

  • Scalais E, Bottu J, Wanders RJ, Ferdinandusse S, Waterham HR, De Meirleir L (2015). Familial very long chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant death: improved survival by prompt diagnosis. American Journal of Medical Genetics Part A, 167A(1), 211-214. [doi: 10.1002/ajmg.a.36803]

  • Scalais E, Chafai R, Van Coster R, Bindl L, Nuttin C, Panagiotaraki C, Seneca S, Lissens W, Ribes A, Geers C, Smet J, De Meirleir L (2013). Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2). European Journal of Paediatric Neurology, 17(6), 625-630. [doi: 10.1016/j.ejpn.2013.05.013]

  • Scalais E, Connerotte AC, Despontin K, Biver A, Ceuterick-de Groote C, Alders M, Kolivras A, Hachem JP, De Meirleir L (2016). Shwachman-Diamond syndrome presenting with early ichthyosis, associated dermal and epidermal intracellular lipid droplets, hypoglycemia, and later distinctive clinical SDS phenotype. American Journal of Medical Genetics Part A, 170(7), 1799-1805. [doi: 10.1002/ajmg.a.37673]

  • Scalais E, Francois A, Nuttin C (1996). [Diagnostic and prognostic value of evoked potentials facing cerebral hypoxia in newborn infants]. Archives de Pédiatrie, 3 Suppl 1, 251s-253s. [doi: 10.1016/0929-693x(96)86058-1]

  • Scalais E, Francois B, Schlesser P, Stevens R, Nuttin C, Martin JJ, Van Coster R, Seneca S, Roels F, Van Goethem G, Lofgren A, De Meirleir L (2012). Polymerase gamma deficiency (POLG): clinical course in a child with a two-stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh’s encephalopathy. European Journal of Paediatric Neurology, 16(5), 542-548. [doi: 10.1016/j.ejpn.2012.01.013]

  • Scalais E, Francois-Adant A, Nuttin C, Bachy A, Guerit JM (1998). Multimodality evoked potentials as a prognostic tool in term asphyxiated newborns. Electroencephalography and Clinical Neurophysiology, 108(2), 199-207. [doi: 10.1016/s0168-5597(97)00076-2]

  • Scalais E, Geron C, Pierron C, Cardillo S, Schlesser V, Mataigne F, Borde P, Regal L (2023). Would early versus late hydroxocobalamin dose intensification treatment prevent cognitive decline, macular degeneration and ocular disease in 5 patients with early-onset cblC deficiency? Molecular Genetics and Metabolism, 140(3), 107681. [doi: 10.1016/j.ymgme.2023.107681]

  • Scalais E, Nuttin C, Seneca S, Smet J, De Paepe B, Martin JJ, Stevens R, Pierart F, Battisti O, Lissens W, De Meirleir L, Van Coster R (2007). Infantile presentation of the mitochondrial A8344G mutation. European Journal of Neurology, 14(11), e3-5. [doi: 10.1111/j.1468-1331.2007.01926.x]

  • Scalais E, Osterheld E, Geron C, Pierron C, Chafai R, Schlesser V, Borde P, Regal L, Laeremans H, van Gassen KLI, van den Heuvel LPWJ, De Meirleir L (Under revision). Parenteral Hydroxocobalamin Dose Intensification in 5 Patients with Different Types of Early Onset Intracellular Cobalamin Defects: Clinical and Biochemical Responses. Journal of Inherited Metabolic Disease.

Hanseob Shin | Antimicrobial | Best Researcher Award

Dr. HanseobShin | Antimicrobial | Best Researcher Award

Postdoc scholar at University of iowa,United States

Dr. Hanseob Shin is a dedicated environmental microbiologist specializing in tracking environmental contamination, microbial ecology, and antimicrobial resistance in water systems. As a Postdoctoral Fellow at the Center for Health Effects of Environmental Contamination at the University of Iowa, he actively investigates the fate and transport of antibiotic-resistant bacteria in various aquatic environments. His research applies CRISPR spacerome analysis and microbial source tracking to understand the dynamics of contamination sources. With extensive experience in environmental microbiology, Dr. Shin has contributed significantly to identifying antibiotic-resistant genes in wastewater and river systems, improving public health risk assessment. He has authored numerous scientific publications in prestigious journals and actively participates in national and international conferences. Through his research, he aims to develop innovative solutions for mitigating microbial contamination in natural and engineered water systems, promoting environmental sustainability and health protection.

Professional Profile

Scopus Profile

ORCID

Education 🎓

Dr. Hanseob Shin obtained his Ph.D. in Earth Sciences and Environmental Engineering from the Gwangju Institute of Science and Technology, South Korea, in 2022. His doctoral research focused on long-term monitoring of antibiotic resistance genes and bacteria in rivers and wastewater treatment plants, providing valuable insights into microbial contamination dynamics. Before his Ph.D., he earned a Bachelor of Science in Molecular Biotechnology from Chonnam National University in 2015, where he developed a strong foundation in microbial genetics and biotechnology. His academic journey has been marked by a keen interest in microbial ecology, antibiotic resistance, and environmental health. Dr. Shin’s education has equipped him with expertise in advanced microbiological techniques, including metagenomics, CRISPR engineering, and microbial source tracking. His interdisciplinary training bridges environmental science and molecular biotechnology, enabling him to address pressing challenges in water quality management and public health protection.

Work Experience 💼

Dr. Hanseob Shin has accumulated extensive experience in environmental microbiology and microbial source tracking. Since 2022, he has been a Postdoctoral Fellow at the Center for Health Effects of Environmental Contamination at the University of Iowa, where he investigates antimicrobial resistance in water systems. Prior to this, he worked as a Postdoctoral Research Associate at the Gwangju Institute of Science and Technology, contributing to research on microbial contamination in wastewater treatment plants. His work has involved the application of molecular and genomic tools to study antibiotic-resistant bacteria in environmental settings. Additionally, he has collaborated with government agencies and research institutions to assess microbial contamination in agricultural and urban water sources. Through his academic and research roles, Dr. Shin has developed a strong expertise in microbial ecology, CRISPR-based bacterial identification, and the environmental impact of antibiotic resistance genes.

Research Interests 🔬

Dr. Hanseob Shin’s research is centered on environmental microbiology, microbial ecology, and the fate and transport of antimicrobial resistance in water systems. He investigates the spread of antibiotic-resistant bacteria in aquatic environments, including wastewater treatment plants, rivers, and agricultural runoff. His work utilizes CRISPR spacerome analysis for strain-level bacterial identification and microbial source tracking to trace contamination origins. Dr. Shin also explores the role of core antibiotic resistance genes as indicators of pollution in wastewater and natural water bodies. His studies contribute to improving strategies for mitigating microbial risks in water systems. Additionally, he examines the genetic diversity of antibiotic-resistant bacteria, aiming to understand their persistence and potential health risks. His research has practical applications in public health, environmental policy, and water treatment technologies, promoting safer water resources and sustainable environmental management.

Awards & Achievements 🏆

Dr. Hanseob Shin has received recognition for his outstanding research contributions in environmental microbiology. In 2022, he was awarded the Outstanding Best Poster Award at the International Symposium and Annual Meeting of the KSABC for his work on antibiotic resistance genes in effluent and receiving water. His research projects have secured significant funding, including a $300,000 grant from the Chicago Community Trust for studying antibiotic-resistant bacteria in Iowa’s concentrated animal feeding operations (CAFOs). He has also received substantial research grants from the Rural Development Administration and the Korea Environmental Industry & Technology Institute for projects related to wastewater treatment and antibiotic-resistant organisms. His contributions as a peer reviewer for high-impact journals further highlight his expertise in the field. Dr. Shin’s accolades reflect his dedication to advancing scientific knowledge on microbial contamination and public health.

Conclusion

Dr. Hanseob Shin is a strong candidate for the Best Researcher Award due to his impactful contributions to environmental microbiology, antibiotic resistance, and microbial tracking. His extensive publication record, research funding, and conference presentations position him as an emerging leader in his field. While he could enhance his profile by expanding his independent research leadership and mentorship roles, his current achievements make him a highly competitive nominee for this prestigious award.

Top Noted Publications 📚

Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance

Authors: Not specified

Year: 2022

Citations: Not specified

Prevalence and Characterization of CRISPR Locus 2.1 Spacers in Escherichia coli Isolates Obtained from Feces of Animals and Humans

Authors: Not specified

Year: 2023

Citations: Not specified

Resistome Study in Aquatic Environments

Authors: Not specified

Year: 2023

Citations: Not specified

Dynamics of Genotypic and Phenotypic Antibiotic Resistance in a Conventional Wastewater Treatment Plant in 2 Years

Authors: Not specified

Year: 2022

Citations: Not specified

Geographical distribution and genetic diversity of Bradyrhizobium spp. isolated from Korean soybean root nodules

Authors: Not specified

Year: 2022

Citations: Not specified

Higher abundance of core antimicrobial resistant genes in effluent from wastewater treatment plants

Authors: Not specified

Year: 2022

Citations: Not specified

Phylogenetic diversity and spatiotemporal dynamics of bacterial and microeukaryotic plankton communities in Gwangyang Bay of the Korean Peninsula

Authors: Not specified

Year: 2022

Citations: Not specified

Emergence of High Level Carbapenem and Extensively Drug Resistant Escherichia coli ST746 Producing NDM-5 in Influent of Wastewater Treatment Plant, Seoul, South Korea

Authors: Not specified

Year: 2021

Citations: Not specified

Metagenomic exploration of antibiotic resistome in treated wastewater effluents and their receiving water

Authors: Not specified

Year: 2021

Citations: Not specified

High genetic diversity of Vibrio parahaemolyticus isolated from tidal water and mud of southern coast of South Korea

Authors: Not specified

Year: 2019

Citations: Not specified

Metagenomic analysis reveals the prevalence and persistence of antibiotic- and heavy metal-resistance genes in wastewater treatment plant

Authors: Not specified

Year: 2018

Citations: Not specified

Shahinaz Mohamed | Clinical Research | Best Researcher Award

Dr. Shahinaz Mohamed | Clinical Research | Best Researcher Award

Clinical Research Assistant at King Abdullah International Medical Research Center, Saudi Arabia

Dr. Shahinaz F. Mohamed is a highly experienced Medical Writer and Clinical Research Professional with over 12 years of expertise in the medical research field. She holds a Master of Public Health (MPH) from the University of Essex, UK, and is a Certified Clinical Research Associate (CCRA®). With a strong background in clinical trials, medical writing, and regulatory compliance, she has played a pivotal role in developing and managing clinical study protocols, ethical review processes, and scientific publications. Currently, she serves as a Senior Clinical Research Epidemiologist & Medical Writer at King Abdullah International Medical Research Center (KAIMRC), Saudi Arabia. Dr. Mohamed has significantly contributed to peer-reviewed medical journals, showcasing her expertise in public health, evidence-based medicine, and digital health research. Her work in Good Clinical Practice (GCP) training, clinical trial documentation, and regulatory compliance has established her as a key figure in the field of clinical and translational research.

professional profiles📖

ORCID

Google scholar

Education 🎓

Dr. Shahinaz Mohamed has a diverse and well-rounded educational background in public health, clinical research, and medical sciences. She earned her Master of Public Health (MPH) from the University of Essex, UK, in 2019, which provided her with a strong foundation in epidemiology, healthcare policy, and biostatistics. She further enhanced her qualifications by obtaining the Certified Clinical Research Associate (CCRA®) from the USA in 2022, demonstrating her expertise in clinical trials and regulatory compliance. Additionally, she holds a Certified Clinical Research Coordinator (CCRC®) certification from KSA (2013), further establishing her credibility in research methodology and ethical compliance. Her academic journey began with a Diploma of Higher Education in Histopathology from Egypt (2006) and a Bachelor of Veterinary Medicine from Egypt (2004), providing her with deep knowledge in biomedical sciences and medical research. Her comprehensive education has equipped her with the skills necessary for high-quality clinical research and medical writing.

work Experience💼

Dr. Shahinaz Mohamed has been an integral part of the clinical research field for over a decade, primarily serving as a Senior Clinical Research Epidemiologist & Medical Writer at King Abdullah International Medical Research Center (KAIMRC), Saudi Arabia, since 2011. In this role, she has been responsible for developing clinical study protocols, drafting case report forms, and preparing informed consent documents. She has also played a key role in the scientific and ethical evaluation of research proposals for Institutional Review Board (IRB) approval, ensuring compliance with Good Clinical Practice (GCP) and international regulatory standards. Her work includes conducting literature reviews, statistical analysis, and data interpretation for scientific publications, as well as peer-reviewed journal articles and systematic reviews. In addition, she has contributed as a Research Proposal Reviewer and IRB Member, evaluating preclinical and clinical studies and advising investigators on study design, ethical considerations, and publication guidelines.

Research Focus

Dr. Shahinaz Mohamed’s research primarily focuses on infectious diseases, clinical trials, endocrinology, and public health. Her work in infectious disease epidemiology has contributed to the treatment and management of conditions such as Middle East respiratory syndrome (MERS-CoV) and diabetes. She has played a vital role in clinical trials and evidence-based medicine, ensuring the development of robust interventional studies to improve patient outcomes. In the field of endocrinology and metabolic disorders, she has examined the impact of insulin therapy and lipid metabolism in diabetes patients. Additionally, her research extends to medical ethics and GCP compliance, ensuring that clinical trials adhere to the highest ethical standards. She has also been actively involved in digital health and healthcare data analysis, exploring the adoption of personal health records and AI-driven medical research solutions. Her multidisciplinary research contributes to medical advancements and improved healthcare policies.

Awards & Honors🏆 

Dr. Shahinaz Mohamed has been recognized for her significant contributions to clinical research and medical writing through various awards and honors. She earned the prestigious Certified Clinical Research Associate (CCRA®) certification from the USA in 2022, affirming her expertise in clinical trials and research ethics. Additionally, she has been an ICH-GCP Instructor and Certification Trainer, providing Good Clinical Practice (GCP) training for medical professionals. She has been invited as a presenter at Research Methodology & Biostatistics Workshops (Nature Research Academies, 2022) and has served as a Clinical Research Capability Trainer for AstraZeneca in 2022. Her participation as a speaker at Annual Clinical Research Symposiums (KAIMRC, Almoosa Specialist Hospital) further highlights her influence in the medical research community. Recognized for her expertise in Regulatory & Quality Management in Clinical Research (SFDA, FDA compliance), she continues to be a key figure in clinical research training and regulatory affairs.

Skills 🛠️ 

Dr. Shahinaz Mohamed possesses a diverse skill set that allows her to excel in clinical research, scientific writing, and regulatory compliance. She is highly proficient in medical and scientific writing, specializing in manuscripts, abstracts, and study protocols. Her expertise in clinical research methodology and statistical analysis (SPSS, STATA, R) enables her to conduct comprehensive data analysis and interpretation. She is skilled in Institutional Review Board (IRB) submissions and compliance, ensuring ethical approval of clinical trials. Additionally, she is a Good Clinical Practice (GCP) instructor, providing training in research ethics and regulatory compliance. Her proficiency in systematic reviews, manuscript editing, and peer-review coordination makes her a highly sought-after expert in medical publishing. She is also well-versed in digital health research and AI-driven healthcare solutions, contributing to the advancement of innovative medical technologies. With fluency in English and Arabic, she effectively communicates research findings and regulatory guidelines across diverse medical communities.

Conclusion✅

Shahinaz F. Mohamed possesses outstanding qualifications for the Best Researcher Award, given her strong research background, publication record, expertise in clinical research, and commitment to research ethics and training. Her contributions in medical writing, research methodology, and regulatory compliance make her a highly competitive candidate. To further strengthen her profile, she may consider leading independent research projects, contributing to groundbreaking studies, and securing research grants. Nevertheless, her current accomplishments make her a strong contender for this prestigious award. 🚀🏆

📚Publications to Noted

Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial

Authors: YM Arabi, A Alothman, HH Balkhy, A Al-Dawood, S AlJohani, S Al Harbi, …

Citations: 370

Year: 2018

Molecular Analysis of Congenital Hypothyroidism in Saudi Arabia: SLC26A7 Mutation Is a Novel Defect in Thyroid Dyshormonogenesis

Authors: M Zou, AS Alzahrani, A Al-Odaib, MA Alqahtani, O Babiker, RA Al-Rijjal, …

Citations: 72

Year: 2018

Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting

Authors: MD Reem Alamoudi, MD, MHSc, Maram Alsubaiee, MD, Ali Alqarni, MD, Yousef …

Citations: 39

Year: 2017

Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial

Authors: Y Arabi, F Al-Hameed, KEA Burns, S Mehta, S Alsolamy, M Almaani, …

Citations: 14

Year: 2018

The Dialysis Outcomes and Practice Patterns Study Phase 5 in the Gulf Cooperation Council Countries Design and Study Methods

Authors: Pisoni, Ronald L., BA Bieber, J Al Wakeel, S Al Arrayed, N Alkandari, …

Citations: 11

Year: 2016

Surveillance or no surveillance for deep venous thrombosis and outcomes of critically ill patients: a study protocol and statistical analysis plan

Authors: YM Arabi, KEA Burns, F Al-Hameed, S Alsolamy, M Almaani, …

Citations: 7

Year: 2018

Replacing protein via enteral nutrition in a stepwise approach in critically ill patients: the REPLENISH randomized clinical trial protocol

Authors: YM Arabi, HM Al-Dorzi, M Sadat, D Muharib, H Algethamy, F Al-Hameed, …

Citations: 6

Year: 2023

The effect of intermittent pneumatic compression on deep-vein thrombosis and ventilation-free days in critically ill patients with heart failure

Authors: HM Al-Dorzi, A Al-Dawood, FM Al-Hameed, KEA Burns, S Mehta, J Jose, …

Citations: 5

Year: 2022

Statistical analysis plan for the replacing protein via enteral nutrition in a stepwise approach in critically ill patients (REPLENISH) randomized clinical trial

Authors: YM Arabi, HM Al-Dorzi, O Aldibaasi, M Sadat, J Jose, D Muharib, …

Citations: 3

Year: 2024

Association of advanced lipoprotein subpopulation profiles with insulin resistance and inflammation in patients with type 2 diabetes Mellitus

Authors: A Bakillah, KK Obeid, M Al Subaiee, AF Soliman, M Al Arab, SF Bashir, …

Citations: 3

Year: 2023

 

Fackson Mwale | Osteoarthritis | Best Researcher Award